SoverAI
PlatformRegionsCompliancePricingSecurityDocs
Sign inConsole
SoverAI

The control plane for agentic AI in environments where data residency is not optional — designed for board, regulator, and institutional diligence.

SOC 2ISO 27001HIPAA-ready

enterprise@soverai.ai · Press · Security

Product

  • Platform
  • Regions
  • Pricing

Industries

  • BFSI
  • Healthcare
  • Government

Trust

  • Compliance
  • Security
  • Documentation
  • Privacy
  • Terms
© 2026 SoverAI. Public site content is for investor and customer diligence; binding terms are in your order form and MSA.

Payers · providers · trials

AI that stays inside the care boundary you promised patients

Healthcare is already data-intensive; adding generative models without a residency story is how privacy officers lose sleep. SoverAI builds agents where OCR, retrievers, and summarizers share the same scope as the rest of your EHR, claims, and trial systems — and produce evidence your IRB and CISO can interrogate together.

PHI

Data class as first control

US / UK / IN

Patterns we map in pilots

BAA

Context for covered workloads

HITL

Clinical gates where required

The gap between innovation and defensibility

Regulators expect the same level of control over AI as for core systems — with clearer lineage and data boundaries than most cloud-native stacks default to.

OCR and unstructured notes

They need to be processed where your BAAs and DPA say they live — not in a public endpoint because it was the fastest to wire.

Prior auth and benefits

Narrative generation must be consistent with your policy engine and your appeal process, with line-of-sight to the exact policy version and channel.

Trials and RWE

Cohort selection and safety surveillance need consent boundaries that survive statistics and privacy review — at the same time you want modern NLP.

What SoverAI changes

A single control plane: jurisdiction-first routing, agent guardrails, and evidence-grade audit you can hand to a supervisor without re-architecting your estate.

Residency-native agents

Environments and retrievers are parented in-region. The default is not a global index with a best-effort filter — it is a build-time guarantee your privacy office can test.

PHI-scoped access

Service principals, break-glass, and human-in-the-loop are modeled the way your IAM team already requires for clinical systems, not a second shadow directory.

Protocol-aware workflows

Template agents for PA, CDI, and pharmacovigilance handoffs with explicit human acknowledgement where your SOPs still require a signature.

Representative high-value scenarios

Patterns we see in diligence and architecture reviews with regulated customers — not exhaustive, but designed to be concrete for internal steering committees.

Prior authorization and appeals

First-pass review with your medical policy graph, with appeal packets that quote the right statute and your internal policy version.

Faster turnarounds and fewer incomplete submissions — without a black-box letter your member services team cannot explain.

Revenue cycle and documentation integrity

Point-of-care and back-office support that does not require a second copy of clinical text in a ‘shadow’ warehouse.

DRG and HCC integrity improvements with a provable data path to CDI and compliance.

Clinical trial operations

Triage, query resolution, and safety narrative assistance with study-specific consent and site boundaries.

A single auditable line from protocol to model action that IRB and QA can re-run in inspection prep.

Controls your risk committee can inspect

Mapped to the frameworks your legal and second-line teams already use — with exportable evidence bundles per region.

  • ·PHI/PII class routing with explicit model and tool allowlists; no cross-class retrieval by default.
  • ·Immutable audit of access to sensitive objects, including agent actions and retriever hits, with redaction for secondary use where required.
  • ·Business associate and controller/processor terms aligned to the region and legal entity in your chart — not a one-size DPA for the whole world.

Regulatory context: HIPAA, CMS / ONC expectations, NHS DSPT-style patterns in the UK, and emerging national health privacy regimes in India and the Middle East — as a living matrix, not a one-time slide for the board offsite.

Read how frameworks map to controls →

Start with a residency review

We will map your data classes, model catalog, and regulator expectations to a deployable control-plane design — with exportable artifacts for legal and security stakeholders.

Email enterprise

Further reading

Security & trustCompliance mappingDocs overview